LLY compared with XENE: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

XENEXenon Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

XENEXenon Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

XENE

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.1%▼−1.84%×0.20

May 8 '26±10.3%▲+0.79%×0.08

= impliedLLY realized, solidXENE realized, hatchedOne scale, both sides: full bar = 31%× = |realized| ÷ impliedSource: market data

Q1 FY26

±30.3%

▼−3.76%

×0.13

Nov 4 '25±8.7%▼−4.94%×0.56

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

XENEXenon Pharmaceuticals Inc.

39.15▲+3.90%· post 39.07

ClosedNov 6 '26

Mkt cap$3.8BRevenue$8MQ1 FY25Revenue—

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

XENEXenon Pharmaceuticals Inc.

1,360.90▼−0.28%post 1,358.90

Price

39.15▲+3.90%post 39.07

$1.2T

Mkt cap

$3.8B

Q3 FY26$24.4B

Revenue

$8MQ1 FY25

FY25$65.2B

Revenue

—

LLY1,360.90▼−0.28%vsXENE39.15▲+3.90%ClosedNov 6 '26